These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18971286)

  • 1. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.
    Anderson AE; Swan DJ; Sayers BL; Harry RA; Patterson AM; von Delwig A; Robinson JH; Isaacs JD; Hilkens CM
    J Leukoc Biol; 2009 Feb; 85(2):243-50. PubMed ID: 18971286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic dendritic cells induced by BD750 ameliorate proinflammatory T cell responses and experimental autoimmune encephalitis in mice.
    Zhou Y; Leng X; Li H; Yang S; Yang T; Li L; Xiong Y; Zou Q; Liu Y; Wang Y
    Mol Med; 2017 Oct; 23():204-214. PubMed ID: 28960227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4
    Anderson AE; Swan DJ; Wong OY; Buck M; Eltherington O; Harry RA; Patterson AM; Pratt AG; Reynolds G; Doran JP; Kirby JA; Isaacs JD; Hilkens CM
    Clin Exp Immunol; 2017 Jan; 187(1):113-123. PubMed ID: 27667787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
    Spiering R; Jansen MAA; Wood MJ; Fath AA; Eltherington O; Anderson AE; Pratt AG; van Eden W; Isaacs JD; Broere F; Hilkens CMU
    J Transl Med; 2019 Nov; 17(1):375. PubMed ID: 31727095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
    Stoop JN; Robinson JH; Hilkens CM
    Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression.
    Hegde S; Pahne J; Smola-Hess S
    FASEB J; 2004 Sep; 18(12):1439-41. PubMed ID: 15247147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.
    Volchenkov R; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2013; 15(5):R114. PubMed ID: 24025795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
    García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
    J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature.
    Robertson H; Li J; Kim HJ; Rhodes JW; Harman AN; Patrick E; Rogers NM
    Front Immunol; 2021; 12():733231. PubMed ID: 34745103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin.
    Navarro-Barriuso J; Mansilla MJ; Naranjo-Gómez M; Sánchez-Pla A; Quirant-Sánchez B; Teniente-Serra A; Ramo-Tello C; Martínez-Cáceres EM
    Sci Rep; 2018 Oct; 8(1):14985. PubMed ID: 30297862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells.
    Volchenkov R; Karlsen M; Jonsson R; Appel S
    Scand J Immunol; 2013 Apr; 77(4):246-54. PubMed ID: 23442246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells.
    Anderson AE; Sayers BL; Haniffa MA; Swan DJ; Diboll J; Wang XN; Isaacs JD; Hilkens CM
    J Leukoc Biol; 2008 Jul; 84(1):124-33. PubMed ID: 18430785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells.
    Ozeri E; Mizrahi M; Shahaf G; Lewis EC
    J Immunol; 2012 Jul; 189(1):146-53. PubMed ID: 22634621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.
    Popov I; Li M; Zheng X; San H; Zhang X; Ichim TE; Suzuki M; Feng B; Vladau C; Zhong R; Garcia B; Strejan G; Inman RD; Min WP
    Arthritis Res Ther; 2006; 8(5):R141. PubMed ID: 16911769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
    Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
    Front Immunol; 2019; 10():2068. PubMed ID: 31555285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response.
    Gosset P; Pichavant M; Faveeuw C; Bureau F; Tonnel AB; Trottein F
    Eur J Immunol; 2005 May; 35(5):1491-500. PubMed ID: 15816013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory Effects of 1,25-Dihydroxyvitamin D
    Lee WP; Willekens B; Cras P; Goossens H; Martínez-Cáceres E; Berneman ZN; Cools N
    J Immunol Res; 2016; 2016():5392623. PubMed ID: 27703987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.
    Djedovic N; Jevtić B; Mansilla MJ; Petković F; Blaževski J; Timotijević G; Navarro-Barriuso J; Martinez-Caceres E; Mostarica Stojković M; Miljković Đ
    Immunobiology; 2019 May; 224(3):470-476. PubMed ID: 30765133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.